Active substance
Cefadroxil
- SFDA 18
- Health Canada 3
- US price lines 5
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CEFADROX 250MG-5ML SUSPENSION | 50 mg/ml | Suspension · Oral use | 1 Bottle | SAR 22.15 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| CEFADROX 500MG CAPSULE | 500 mg | Capsule · Oral use | 12 Blister | SAR 30.55 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| CEFADROX 500MG-5ML SUSPENSION | 100 mg/ml | Suspension · Oral use | 1 Bottle | SAR 44.55 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| MIDROXIL 250MG\5ML SUSP | 50 mg/ml | Oral suspension · Oral use | 1 Bottle | SAR 12.85 | Generic · Prescription | Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co. | Valid |
| MIDROXIL 500 MG CAPSULE | 500 mg | Capsule · Oral use | 12 Blister | SAR 19.25 | Generic · Prescription | Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co. | Valid |
| MIDROXIL 500MG\5ML SUSP. | 100 mg/ml | Oral suspension · Oral use | 1 Bottle | SAR 20.40 | Generic · Prescription | Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co. | Valid |
| ROXIL 250MG-5ML SUSP. | 50 mg/ml | Powder for oral suspension · Oral use | 1 Bottle | SAR 24.60 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| ROXIL 500MG CAPS | 500 mg | Capsule, hard · Oral use | 20 Blister | SAR 56.60 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| BIODROXIL 1 GM FILM COATED | 1 g | Film-coated tablet · Oral use | 12 Blister | SAR 47.25 | Generic · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
| BIODROXIL 125MG\5ML | 25 mg/ml | Suspension · Oral use | 1 Bottle | SAR 14.55 | Generic · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
| BIODROXIL 250MG\5ML | 50 mg/ml | Suspension · Oral use | 1 Bottle | SAR 24.40 | Generic · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
| BIODROXIL 500MG-5ML SUSPENSION | 100 mg/ml | Suspension · Oral use | 1 Bottle | SAR 47.95 | Generic · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
| BIODROXIL500MG CAP | 500 mg | Capsule · Oral use | 20 Blister | SAR 49.35 | Generic · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
| CEFADRIL 250MG\5ML SUSPENSION | 50 mg/ml | Suspension · Oral use | 1 Bottle | SAR 10.35 | Generic · Prescription | Ram Pharmaceutical Industries | Withdrawn by MAH · Not Marketed |
| CEFADRIL 500 MG CAPSULES | 500 mg | Capsule · Oral use | 12 Blister | SAR 17.35 | Generic · Prescription | Ram Pharmaceutical Industries | Withdrawn by MAH · Not Marketed |
| ULTRACEF 250MG PWD.FOR SUSP | 50 mg/ml | Powder for suspension · Oral use | 1 Bottle | SAR 27.90 | NCE · Prescription | BRISTOL-MYERS CO | Invalid · Not Marketed |
| ULTRACEF 500MG CAPS | 500 mg | Capsule · Oral use | 20 Blister | SAR 62.90 | NCE · Prescription | BRISTOL-MYERS SQUIBB | Withdrawn by MAH · Not Marketed |
| ULTRACEF 500MG-5ML SUSP | 100 mg/ml | Suspension · Oral use | 1 Bottle | SAR 49.50 | NCE · Prescription | BRISTOL-MYERS CO | Invalid · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE PYELONEPHRITIS; BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION; INTRA-ABDOMINAL INFECTIONS; LOWER URINARY TRACT INFECTIONS; OSTEOMYELITIS; PHARYNGITIS
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-CEFADROXIL | 02240774 | 500 MG | CAPSULE · ORAL | APOTEX INC |
| JAMP CEFADROXIL | 02544792 | 500 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| TEVA-CEFADROXIL | 02235134 | 500 MG | CAPSULE · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CEFADROXIL 1 GM TABLET | $3.37367 | per EA | 23 Sep 2026 |
| US NADAC | CEFADROXIL 250 MG/5 ML SUSP | $0.16745 | per ML | 23 Sep 2026 |
| US NADAC | CEFADROXIL 500 MG CAPSULE | $0.26904 | per EA | 23 Sep 2026 |
| US NADAC | CEFADROXIL 500 MG/5 ML SUSP | $0.26533 | per ML | 23 Sep 2026 |
| US NADAC | CEFADROXIL 500 MG/5 ML SUSP | $0.22431 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Cefadroxil 500mg capsules | £22.38 | 20 capsule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.